Three questions for Boulder-based software company Althea
More results...
Three questions for Boulder-based software company Althea
FDA rejects first application for drug-assisted therapy despite 71% efficacy
MDMA is one step closer to becoming the first FDA-approved psychedelic drug. In October 2023, the Multidisciplinary Association for Psychedelic Studies (MAPS) announced it completed its phase three clinical trial...